Navigation Links
CureLauncher is a New Website That Connects Patients to Trials Across the U.S.
Date:12/6/2012

Bloomfield Hills, MI (PRWEB) December 06, 2012

CureLauncher is bringing people together to advance new treatments for cancer.

Many people don’t know there’s free treatment available at world-class medical sites across America. Only CureLauncher.com translates the complex, medical terminology into easy to understand English. It provides the entry questions to determine if a trial is appropriate for anyone’s specific condition.

People can submit a Request Form to participate or call cureLauncher directly to see if they qualify. This service is entirely free to all users.    

In addition to connecting patients to clinical trials, cureLauncher is also advancing a new treatment for breast cancer, even if the cancer has spread to other parts of the body.

Dr. Lee Roy Morgan is an esteemed cancer researcher and has been awarded research funding by the National Institutes of Health (NIH) for his work. However, government funding cuts to the NIH may prevent Dr. Morgan from advancing his new breast cancer treatment; abbreviated name is DM-CHOC-PEN.

Donations made on cureLauncher will allow Dr. Morgan to continue developing this cure.

“We are working through the FDA to move this program forward as quickly as possible” said Dr. Morgan. Ninety one percent of all money donated on cureLauncher will be used to make drug supplies for the next clinical trial. “These donations will make a huge difference toward our goal of improving cancer patients’ lives”.

CureLauncher creates a personal connection to advancing new cancer treatments. Each person who donates $25 or more to Dr. Morgan’s research can write a personal and confidential email and receive Dr. Morgan's reply.

CureLauncher puts the most money possible directly into new cancer treatments. “Each person can see exactly where their contribution is used and be confident that 91% of that money is going directly into advancing a new cancer treatment”, said cureLauncher President, Stephen Goldner, JD, RAC. CureLauncher.com lets you see a new breast cancer treatment in development and connect with the dedicated scientists who are saving lives.    

To learn more, visit http://www.curelauncher.com

Find. Fund. Cure.

About CureLauncher
CureLauncher.com is an online community dedicated to funding new cancer treatments. It connects patients to lifesaving clinical trials and generates support for new cancer treatments in a way never before possible. Advocates of the research connect with each other and leading medical professionals to advance new treatments for cancer.

Read the full story at http://www.prweb.com/releases/cureLauncher/Clinical_Trial_Access/prweb10210154.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
2. BioRestorative Therapies Announces Launch of New Website
3. Prostate Cancer Medical Websites: Friend Or Foe?
4. A New Dawn in Cosmetics Coverage: Cosmetics Design Launches Asia-Pacific News Website
5. Clinical Site Services, Industry Leader in Patient Enrollment Solutions, Announces New Website
6. Critical Process Filtration Announces New Website and Expanded Literature Library
7. JH Technologies Announces Launch of Their New Website
8. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
9. Trade Show Display Company GLM Displays Increase Sales with New E-commerce Website
10. Pittcon 2013 Launches New Website
11. Comprehensive Resource for Food Safety Diagnostics – Romer Labs Launches New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/25/2017)... (PRWEB) , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change ... advocacy, and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
Breaking Biology Technology:
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... -- Acuity Market Intelligence today released the 2017 "Ten ... characterizes 2017 as a "breakout" year for biometrics ... new understanding of the potential benefits these technologies ... are often perceived as threats to privacy and ... Acuity Market intelligence. "However, taken together these technologies ...
(Date:1/24/2017)... 2017  It sounds simple and harmless—an electronic ... vital signs and alerts parents on their smart ... level drops. But pediatric experts argue that such ... no evidence of medical benefits, especially to healthy ... to parents of healthy babies, promising peace of ...
Breaking Biology News(10 mins):